Guru Ownership Trend
Guru Analysis for Generate Biomedicines, Inc. (GENB)
Generate Biomedicines, Inc. (GENB), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q2 2026, a total of 2 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $18.55 M.
Top institutional holders include Catherine Wood and Renaissance Technologies (RenTech).
Institutional sentiment is currently Bullish. This is evidenced by a $13.63 M net inflow during the quarter.
Recent activity highlights Catherine Wood who increased their stake by 157.7%.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q2 2026)
Guru Consensus (Q2 2026)
FAQs for Generate Biomedicines, Inc. (GENB)
Major holders include Catherine Wood ($21.67 M), Renaissance Technologies (RenTech) ($669,486). According to the latest reported data, 2 tracked investment managers collectively hold approximately 1.32 M shares.
According to the latest 13F reporting period, sentiment appears Bullish (Net Buying). There was a net inflow of $13.63 M, with 2 managers increasing positions and 1 managers reducing holdings.
During the most recent reporting period, 0 managers trimmed their positions, while 1 fully exited GENB. The total reported sell value was $297,913.
Yes, 1 managers opened new positions in GENB, and 1 increased their existing holdings. The total reported buy value was $13.93 M.